INT62523
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
In addition morphine also stimulated MOR associated PDGF-beta receptor phosphorylation. | |||||||||||||||
| |||||||||||||||
|
These findings suggest that the phosphorylation of the mu-opioid receptor in the spinal cord under a neuropathic pain-like state may, at least in part, contribute to the reduction in the antinociceptive effect produced by morphine in the mouse. | |||||||||||||||
| |||||||||||||||
|
Under this condition, phosphorylated-mu-opioid receptor-like immunoreactivity was clearly increased on the ipsilateral side in the superficial laminae of the L5 lumbar spinal dorsal horn in nerve-ligated mice. | |||||||||||||||
| |||||||||||||||
|
to the MOR to promote the Src-mediated phosphorylation of the Tyr1325 NMDAR2A subunit. | |||||||||||||||
| |||||||||||||||
|
Periplakin inhibits G-protein activation when MOR is bound by an agonist [18], while PCKI1 inhibits agonist-induced phosphorylation of MOR by G-protein coupled receptor kinase 2 [19]. | |||||||||||||||
| |||||||||||||||
|
Pretreatment with the agonist morphine, followed by drug removal, resulted in a sustained increase of basal mu receptor phosphorylation. | |||||||||||||||
| |||||||||||||||
|
Buprenorphine and full antagonists each antagonized the enhanced mu receptor phosphorylation induced by morphine or DAMGO. | |||||||||||||||
| |||||||||||||||
|
This generally good fit between the efficacies of opiates in mu receptor activation, phosphorylation, and desensitization supports the idea that activated receptor/agonist/G-protein complexes and/or receptor conformational changes induced by agonists are required for agonist-induced mu receptor phosphorylation. | |||||||||||||||
| |||||||||||||||
|
Buprenorphine and full antagonists each antagonized the enhanced mu receptor phosphorylation induced by morphine or DAMGO. | |||||||||||||||
| |||||||||||||||
|
This generally good fit between the efficacies of opiates in mu receptor activation, phosphorylation, and desensitization supports the idea that activated receptor/agonist/G-protein complexes and/or receptor conformational changes induced by agonists are required for agonist-induced mu receptor phosphorylation. | |||||||||||||||
| |||||||||||||||
|
To better understand the nature of the agonist-induced mu receptor phosphorylation events, we have investigated the effects of a variety of opiate ligands of varying potencies and intrinsic activities on mu receptor phosphorylation and desensitization. | |||||||||||||||
| |||||||||||||||
|
Mu opioid receptors are subject to phosphorylation and desensitization through actions of at least two distinct biochemical pathways: agonist-dependent mu receptor phosphorylation and desensitization induced by a biochemically distinct second pathway dependent on protein kinase C activation (1). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.